CD34 and neoplasm: BALB/C mice with an inducible invasive breast cancer model, employing the 4T1 syngeneic tumor cells, showed a significant reduction in the macrophage and CD34 (vascular endothelial cell marker) marking during the tumor progression phase in the groups that covered higher distances from running on a treadmill (Pettan-Brewer et al., 2014).